| Tag | Content |
|---|
EnhancerAtlas ID | HS019-15291 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr8:28889140-28891710 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ELF5 | MA0136.2 | chr8:28891073-28891084 | TACTTCCTGGT | - | 6.02 | | JUND(var.2) | MA0492.1 | chr8:28890926-28890941 | CATGACCTCATTTCA | - | 6.07 | | MEOX2 | MA0706.1 | chr8:28891537-28891547 | AGTAATTAAC | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10799 | chr8:28890410-28891472 | CD19_Primary | | SE_11010 | chr8:28879272-28897923 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr8 | 28890080 | 28891183 | | chr8 | 28890628 | 28890717 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I029032 | chr8 | 28890451 | 28891206 |
|
Enhancer Sequence | CTATGTGTCC TTATGGAAAT TGCTTATTAT AAATGACTTT AATAACCATA CCTATCTAAT 60
AGGAGTACTT TGGTATGGCT TTAGGAACAT ACCTTTTCTA ATAGTGTTGC TCCTCAACAC 120
TGTGCCCCGT GCTGAGGAGT GTGGAAAGAT TAGCTCCTAG CCCTGGCAGG CTCAGTCCAT 180
TGGAGGAGTC AGGTTAAAAA TGTCATGCAA GAGATGTGTA CCAAGTACAA TAAGGACACA 240
GGAGAGTGGT GCAAGGAAAG GAAACCCTGA GGTGACAGTG GAGTGGGGTC CTGGAGAGCA 300
GTACAGTTTC AATGAGGTGA GAAGAGGAAG AATGACATGG CCAGTAGTGG GAGCACCATG 360
TGCAAAGGCA CAGAGGCTGG AAAAATGAGG CTGCTGAGTG TCTGCTCAGT TGGGTGGGAA 420
ATGAGGCTGA GTGAGTAGGT TGCAGCCAGA TTGGGAATGA CCTTACATTG CGACATTTGC 480
AACATTTGTC TTTCGCAAAG CATCCTATTT GTATCTATGT GAAGTAAGTT CTTTTAATAA 540
CCAAAAAACA TTTTTCTTCA TCAGTTTTTG GGGTTGTTGG TGCCACTTTT CTCCCAGATA 600
TAAAACAGAA GTAGTAACTC TTTCATGCCA ATGATTCAAA CTTTTTTGGG GGTGGGAGGA 660
GGGGGGTGGA TTTTCTGTTA ATATTTGTAA AACATCCTGG GAATTAAAAA ATTGAAACTG 720
TTTTGAAAAA TCTTTCTAGC CTTCTTTAAG ACAGAAGCCT AAGTAAGATT CTCCTTTCTA 780
CATGATCAAG GAAACATCTT GAAATTCCAG TCATTTTCAA TTAGAAAAAA AAAAAATCTT 840
TTGATCAATT TTTTTTTCCT GCTGATTTGT GTTACACAGG TACATTGTTA ACAAAAATTA 900
TAAAATTCAG TTTTTCTTTA ACTGACTTCT ATTATAAAGG TGCATTGCTA GGATGAAAAT 960
TTGGGCAATA TCTTTGCCAG AATGAATTAT TTCACCATCT GCTAAGTAAA GTTGACTTGG 1020
TATTTCAGTG GTGCAGTTTT TATGCTCCTT TGGGCTAGGG TTTGGTTATA CTCGGCTGGT 1080
CTATAGGCTG GCATAGTGCT GTATGTAAAG TCTGATATTA CAGAGTGTCA CTTGAACTTG 1140
ATTGAATATT TAAGAAGATC CTATAACTTT AACAAAATTA GAAAATATTA CCACCCTCTT 1200
TCCCCCACCG TACATGTTAG ACTCAAGGTG GGAGATACGG TAGTGCAGTA TTTTCTAATT 1260
TTGTTAAAAT CGTAAGGCAT TCAAATCAAT TCGATGATTG ATAATAATAA TCAAAAGATT 1320
TAAAGTGATC CAATCAAAAT GACTCAAAAA ACAGGAAAAT TACTTTTGAA TGCCTCAGTG 1380
TTGTTTTCCT TAGAACATTA TATCATTCTC ATCCATTAAA AAAACATTTT GTGGGAGCAG 1440
AGTTGAGTCC TTTAAAATGT GATGTTTGTC CTGGCCTATA ATGAATGAGG ATGTAAAACG 1500
TGCACTCTGC CCTCCCTTAG GCTGTTTTGC CACCACCGCA ACCCCTGGCA AGCTGGTCTT 1560
CCTTCCTGTC TCTTCTGATG TCATTGCTGT TCTAAGAGAA CATGCTGGAA GAATACACTA 1620
TAAATTTTGG GATTAATTAT GCCGGAAGTT GTATTTTAAA AGAAGTTTAT CCTCTTTTAT 1680
ACTCCTTATG GAATGACTCG GGTGGAACAT AATGAACTAC ACCTCCTGTA TCTCTCTACA 1740
AATAGAAGGC AGTTCTTAAC ATTTAAATAG ACAGCAGGAG CCTGGACATG ACCTCATTTC 1800
AATCCATTAG ACTATTTGAG GAAAAAACAA CAAAATTTTC CCACTTATTG ACAGGTAAAG 1860
TTATCCCAAT CCATTTCTCA TAGCCAGTAA GAAGATGAAC TGTGCTTAAA TGTATTTTAA 1920
AATTGGCAAA TTATACTTCC TGGTTCCTTT TTGGTCAAAC AGAAATAGCC AGAAGAGAAA 1980
TTATCATGAT GTTTTTGAGG CAGATTAAAA TTTTTCTCTA TCCTCATAGA GATGCTTTGC 2040
TAGCAGTTTC ATTTTGTACA AATGGCATAC CCCTTATTTC TCTAGTCCCC AAGCCAATTA 2100
AACAGGGCAA AAGACCCCAC GTTCCTCATA CAATGTTCTG TGGCCGCAGT TTACAAATAA 2160
ATGAAGCACA GTTAGGTAAA TACTGGTGTT GTATATAATG AGTGACCAAT TAAGTATATG 2220
ATTCATCCCA GAGCAGAATT CTAGGCATCA TATTATAAAC ATTAATACCA AGGGAGATCA 2280
ACTTATAGAC GAATTGGAAA ATCTTCACAG AAAACTAGTG AGCCTTCAAA AACTCAAGCA 2340
AATATTTATT GAGCTTCTAC TTTGTACCAA TCATTGTAAT AGATAACTGA GCAATACAGT 2400
AATTAACAAG ACAAATGTGG TTCTGGCCTT AATGGCATTA AGAAATCATT ATTGTTATAC 2460
TAAACATTCA CAACATGTAC AGAGGCTTAT ATATGTGTTT GGTGTTTGAA GATCTCAGTT 2520
GGTAGGATCT GAACTTGTTG GTGAATATCC AAGTTTGGTT GAGGAAACTT 2570
|
